Center for Research in Transplantation and Translational Immunology

You are here : CR2TI

CR2TI - Homepage

Center for Research in Transplantation and Translational Immunology

Selected publications

  • Sepsis-trained macrophages promote antitumoral tissue-resident T cells. 2024 Nat Immunol. PMID 38684922
  • ​​​​Robust airway microbiome signatures in acute respiratory failure and hospital-acquired pneumonia. 2023 Nat Med PMID 37957375
  • Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis. 2024 JAMA Neurol.  PMID 38345791
  • Blood MMP-9 measured at 2 years after lung transplantation as a prognostic biomarker of chronic lung allograft dysfunction. 2024 Respir Res. PMID 38336710
See more

Progreffe - Make a donation

You too can help advance research in organ transplantation and immunology. Make a donation to Progreffe Fondation that will be used to fund the work of researchers at the CR2TI and the ITUN at the University Hospital of Nantes. Donate

News

Team6_Nature Immunol

Sepsis induces immune changes that persist for months after the disease has resolved. Read the results of our study published in Nature Immunology and discover how sepsis survivors had a lower cumulative incidence of cancer and how a chemokine network released by sepsis-resident macrophages promotes tissue-resident T cells. PMID: 38684922

One-day international symposium on "Immunoinformatics: Uniting Insights from Immunology and Informatics"

Team 3 Integrative Transplantation, HLA, Immunology, and Genomics of Kidney Injury (iTHINK) at CR2TI UMR1064 INSERM, Nantes Université, will host an international symposium on Immunoinformatics on May 24, 2024. The symposium will bring together over 80 researchers and specialists in the field at the MSH Ange Guépin, Nantes.

Team4/3_The Lancet

Questions about the BEST-Fluid Trial? Christophe Masset, Lucile Figueres and colleagues at ITUN and CR2TI are in correspondence in The Lancet with the authors of the clinical study and the use of balanced crystalloid solutions to prevent kidney damage (DGF) after transplantation. Although the results are promising, more research is needed to confirm their efficacy, especially in light of new organ preservation techniques such as machine perfusion. To further reduce DGF, several factors have been identified: minimizing organ damage during surgery, using advanced preservation methods, optimizing anti-rejection medications, and potentially using new treatments for both donors and organs.

Team2_Stem Cell Res Ther

A new approach to treating acute liver failure. Researchers from CR2TI UMR 1064 Nantes with colleagues from GoLiver Therapeutics created frozen, immature liver cells derived from stem cells (GStemHep). In mice with liver failure, a single dose of thawed GStemHep cells improved liver function rapidly, even without immune system suppression. These cells seem to work by reducing inflammation and stimulating the recipient's own liver cells to regenerate. This is a promising new direction for liver disease treatment

Team5_JAMA Neurol

The study published in JAMA Neurol by David Laplaud and colleagues from CR2TI UMR 1064 Nantes and #OFSEP investigated the effectiveness of different treatments for pediatric multiple sclerosis (POMS). They found that using highly effective therapies (HETs) as the first treatment resulted in Reduced relapses, Less MRI activity and Better tolerability. These findings suggest that HETs might be a better first-line treatment for POMS, although long-term safety studies are still needed.

Team6_Nature Medicine

Respiratory microbial dysbiosis is associated with acute respiratory distress syndrome (ARDS) and hospital-acquired pneumonia (HAP) in critically ill patients. Read the results of the validated robust respiratory microbiome signatures associated with ARDS and HAP, published in Nature Med. Such signatures may help to identify promising targets for microbiome therapeutic modulation in critically ill patient. PMID: 37957375

Team6_Intensive care med

Whether interferon gamma-1b prevents hospital-acquired pneumonia in mechanically ventilated patients ? Read the results from the randomized clinical trial published in Intensive care med

NEMO_Team - Brain Communications

Nicot A. et al. identified the e1 sequence of KIR4.1 as an autoantigen of interest in selected group of patients suffering from Multiple Sclerosis. Congratulations to the NEMO_Team of the CR2TI for their paper in Brain Communications.

O'Tablo - le CR2TI à l'honneur

Découverte d'une signature spécifique du microbiote oral dans la sclérose en plaques Conçu par Léo Boussamet (doctorant), Laureline Berthelot (chercheure) et Arnaud Nicot (chercheur) et dessinée à la craie avec Pierre-Olivier Bertho, Emilie Dugast, Alexandra Garcia, Emeline Gauthier, Louise Le Gal et Sita Shah

BioMAdvanced Diagnostics : a new spin-off !

BioMAdvanced Diagnostics created by Dr S brouard and Dr R Danger, a new spinn off from the CR2TI

  • Le CR2TI à la nuit blanche des chercheurs

Follow us on Twitter

Mis à jour le 16 May 2024.
https://cr2ti.univ-nantes.fr/